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Abstract 
Background: The diagnosis of autism spectrum disorder (ASD) made before age 3 has been 
found to be remarkably stable in clinic- and community-ascertained samples.  The stability of an 
ASD diagnosis in prospectively ascertained samples of infants at risk for ASD due to familial 
factors has not yet been studied, however. The American Academy of Pediatrics recommends 
intensive surveillance and screening for this high-risk group, which may afford earlier identification. 
Therefore, it is critical to understand the stability of an ASD diagnosis made before age 3 in young 
children at familial risk. Methods: Data were pooled across 7 sites of the Baby Siblings Research 
Consortium. Evaluations of 418 later-born siblings of children with ASD were conducted at 18, 24, 
and 36 months of age and a clinical diagnosis of ASD or Not ASD was made at each age. Results: 
The stability of an ASD diagnosis at 18 months was 93% and at 24 months was 82%. There were 
relatively few children diagnosed with ASD at 18 or 24 months whose diagnosis was not confirmed 
at 36 months. There were, however, many children with ASD outcomes at 36 months who had not 
yet been diagnosed at 18 months (63%) or 24 months (41%). Conclusions: The stability of an 
ASD diagnosis in this familial-risk sample was high at both 18 and 24 months of age and 
comparable with previous data from clinic- and community-ascertained samples. However, almost 
half of children with ASD outcomes were not identified as being on the spectrum at 24 months and 
did not receive an ASD diagnosis until 36 months. Thus, longitudinal follow-up is critical for children 
with early signs of social-communication difficulties, even if they do not meet diagnostic criteria at 
initial assessment. A public health implication of these data is that screening for ASD may need to 
be repeated multiple times in the first years of life. These data also suggest that there is a period of 
early development in which ASD features unfold and emerge but have not yet reached levels 
supportive of a diagnosis. 
 
Abbreviations: American Academy of Pediatrics (AAP), Autism Diagnostic Observation Schedule 
(ADOS), autism spectrum disorder (ASD), Baby Siblings Research Consortium (BSRC), clinical 
best estimate (CBE), false negative (FN), false positive (FP), true negative (TN), true positive (TP) 
 
  
Introduction 
The stability of an autism spectrum disorder (ASD) diagnosis made at a young age is of 
high interest, given the impact of early intervention, the provision of which requires early 
identification. While studies performed over the past two decades robustly demonstrated a high 
degree of stability in children aged three years or older at initial diagnosis (Woolfenden et al., 
2012), there was initial concern about the stability of diagnosis for children identified before age 3. 
Both clinicians and researchers raised important questions, given the costs of early autism 
treatment, about the youngest age at which a reliable diagnosis could be made. In many 
communities, there was a general reluctance to diagnose children before age three. Questions 
about the permanence of diagnosis have been highlighted by recent empirical reports of children 
who, in middle or later childhood, no longer meet criteria for ASD (Anderson, Liang & Lord, 2014; 
Fein et al., 2013; Orinstein et al., 2014). However, in recent years, multiple studies have 
demonstrated impressive stability in children diagnosed before three years as well, with a meta-
analysis reporting an overall stability rate of 86.3% for maintaining an ASD diagnosis over time 
(Rondeau et al., 2011). Similar findings were reported by Woolfenden et al. (2012) in a systematic 
review of 10 studies of toddlers diagnosed before their third birthday. 
A review of stability and other classification indices from all previous studies of children 
younger than 36 months at first diagnosis was conducted and can be seen in Supplemental Table 
S1 [available online].  The table aggregates across ASD subtypes and uses dichotomous 
classifications of ASD and Not ASD. The first set of studies reported in Table S1 followed only 
children with a diagnosis of ASD and did not include a comparable sample of children without ASD. 
Positive predictive value, which reflects stability of the diagnosis, is high, with a range of 63% to 
100% across five investigations. Although stability rates and numbers of false positives can be 
calculated from these studies, they cannot address another important aspect of classification 
accuracy, false negative rates. False negatives may reflect missed diagnoses, later onset of 
symptoms, and/or borderline phenotypes that result in initial clinical uncertainty and caution in 
making early diagnoses. Therefore, longitudinal follow-up of children without autism spectrum 
diagnoses at the initial evaluation is critical to understanding clinical decision-making, although it is 
not formally needed for calculation of stability.  
The next group of studies reported in Table S1 includes children with and without ASD at 
Time 1 so that additional classification parameters can be calculated (sensitivity, specificity, etc.). 
Across 8 studies with clinically ascertained samples, the positive predictive value ranged from 72% 
to 100% (with half of the studies over 93%) and the negative predictive value ranged from 67% to 
100% (half the studies over 89%). These classification indices are highly influenced by the base 
rate of the condition in the samples studied (Altman & Bland, 1994). Using samples ascertained 
from clinics, where there has already been a degree of concern raised that was sufficient to bring 
the child to clinical attention, is likely to increase the base rate of ASD, in turn biasing rates of false 
positives and negatives, and increasing stability estimates. 
Community-ascertained samples have the potential to provide less biased psychometric 
indices of classification accuracy. Four such studies are summarized last in Table S1. The positive 
predictive value ranged from 83% to 100%, comparable to the estimates for clinically ascertained 
samples. For practical reasons, many community-based studies employ a pre-screening design, in 
which only those who screen positive at Time 1 are followed longitudinally. For example, van 
Daalen et al. (2009) screened 31,724 children through primary care visits at 14 months of age and 
then followed 131 of the screen-positives for 12 months to calculate stability indices. Similarly, 
Guthrie and colleagues (2013) performed a two-step screening of 5,419 children in primary care 
and then followed 82 children who screened positive for two years to provide their estimates of 
stability. Thus, even in these community-based studies, the base rates of ASD, and thus the 
stability estimates, may have been overestimated by the screening process and sampling frame.  
Another type of sample that may contribute to understanding the stability of early ASD 
diagnoses is a familial-risk sample. In such studies, participants at familial risk for ASD by virtue of 
having an older affected sibling are generally enrolled in longitudinal studies in early infancy, 
before the initial behavioral signs are usually evident (Ozonoff et al., 2010) and prior to when 
parents begin to report concerns (Hess & Landa, 2012; Ozonoff et al., 2009). They have not been 
“pre-screened” based on symptoms before the initial evaluation, potentially reducing such sampling 
biases that may influence stability. In addition to identifying young children with ASD outcomes to 
follow, such samples also identify children with typical development and those with a wide range of 
clinical presentations, including subclinical difficulties in the core areas associated with ASD 
(Messinger et al., 2013; Ozonoff et al., 2014). Given the potential for much earlier detection, 
diagnosis, and treatment of children with a positive family history (Johnson et al., 2007; Ozonoff et 
al., 2011), it is critical to examine the stability of early classification in young children at familial risk 
of ASD. The current study had two aims: 1) to examine the stability at 36 months of a clinical 
diagnosis of ASD made at 18 and 24 months of age in infants at familial risk for ASD and 2) to 
explore phenotypic differences among children who were correctly and incorrectly classified at 18 
and 24 months. Addressing these aims required a large sample and thus the present study utilized 
data from a multi-site cohort of infants whose data were collected as part of an international 
collaboration to study infants with an older sibling with ASD.  
Method 
Participants 
The Baby Siblings Research Consortium (BSRC) is an international network that, with 
support from Autism Speaks, pools data from individually-funded research sites to study the 
development of infants at familial risk for ASD. The present analyses were carried out using data 
contributed from 7 sites (University of Alberta, Dalhousie University, Kennedy Krieger Institute, 
McMaster University, University of California – Davis, University of Toronto, Yale University) whose 
procedures and common measures permitted data pooling. Informed consent was obtained at 
each site prior to data collection, as well as Institutional Review Board approval to collect and 
analyze de-identified data from all sites. 
Infant participants were later-born biological siblings of a child with ASD (99% were full 
siblings). Diverse community enrollment strategies were employed across sites, including 
recruitment from clinics and agencies serving individuals with ASD, community events 
(conferences, health fairs) targeted at families affected by ASD, other ASD studies at respective 
sites’ universities, websites targeted to ASD, word of mouth (parents referring other parents), fliers 
posted in the community, mailings, and media announcements. Inclusion required a documented 
diagnosis of DSM-IV Autistic Disorder, Asperger Disorder, or Pervasive Developmental Disorder 
Not Otherwise Specified in the affected older sibling and no identified neurological or genetic 
condition in the infant or older sibling that could account for an ASD diagnosis (e.g., fragile X 
syndrome). Additional inclusion criteria were maximum enrollment age of 18 months, outcome 
assessment age of 36 months, and availability of both a clinical diagnosis (ASD or not ASD) and 
scores on the Autism Diagnostic Observation Schedule (ADOS) at 18, 24, and 36 months of age.  
For families with multiple enrolled infants, only the infant recruited at the youngest age was 
included. All BSRC sites meeting these inclusion criteria were included in the present analyses, 
resulting in a total sample size of 418 participants across seven sites.  
Measures 
Clinical Best Estimate (CBE) Diagnosis: Each site had established procedures for making 
clinical diagnoses at 18, 24, and 36 months, including: 1) ADOS administration by a research-
reliable examiner, 2) clinical diagnosis using DSM-IV criteria, 3) diagnosis made or verified by 
licensed clinicians, and 4) 36-month outcome assessments performed by examiners unaware of 
risk group and previous diagnostic decisions. Although this study was initiated prior to the 
publication of DSM-5 and diagnoses were made initially using DSM-IV criteria, in order to be 
consistent with current practice, and given the inconsistent application of the DSM-IV sub-
categories (Lord et al., 2012) that may be especially the case in younger children, all clinical 
diagnoses were dichotomized as ASD or Not ASD for analyses.  
Autism Diagnostic Observation Schedule (ADOS; Lord et al., 2002): The ADOS is a 
standardized protocol that measures symptoms of ASD and provides an empirically derived cutoff 
for ASD that has high inter-rater reliability and construct validity. The 2002 communication+social 
interaction algorithm score was used because item-level data, necessary for calculation of newer 
algorithms, was not available from all sites.  
Mullen Scales of Early Learning (Mullen, 1995): This is a standardized developmental test 
for children birth to 68 months that provides T scores (mean=50, SD=10) for nonverbal cognitive, 
receptive and expressive language, and gross and fine motor skills. The Mullen scales have 
excellent internal consistency and test-retest reliability.  
Demographic information was collected at each site (see Table 1). Parent-reported race 
and ethnicity classifications of the infant were collapsed for analysis into two dichotomous variables 
(Caucasian/Not Caucasian and Hispanic/Not Hispanic). Another dichotomous variable was created 
indicating whether the infant’s family was simplex (one older sibling with ASD) or multiplex (more 
than one older sibling with ASD). 
-------------------------------------------------------- 
Insert Table 1 about here 
-------------------------------------------------------- 
Statistical Approach  
   Psychometric measures of the performance of a CBE diagnostic classification at 18 and 24 
months were computed.  Differences in sensitivity and specificity for 18- and 24-month CBE 
diagnostic classification were tested using McNemar’s test (Li & Fine, 2004). The positive and 
negative predictive values of the 18- and 24-month diagnoses were compared using Wald test 
statistics derived from the weighted least square method for analyses of binary data (Wang, Davis 
& Soong, 2006). 
To examine group differences in ADOS and Mullen scores at the 18-, 24-, and 36-month 
visits, mixed-effects linear models (Laird & Ware, 1982) were employed. These models are flexible 
and allow for unequally spaced and missing observations. All core models included fixed effects for 
group membership, the linear and the quadratic effect of age (centered at 18 months), and the 
interaction between group and the linear age effect. To account for the correlated nature of the 
data, the core models included two random effects for child-specific intercepts and slopes, as well 
as a random effect for site.  Additional fixed terms (for the interaction of the quadratic effect of age 
with group and for ADOS module) were also added to the core model and tested. These terms 
were retained in the models only if they were significant.  
Residual analyses and graphical diagnostics were used to determine that model 
assumptions were adequately met. Positive and negative predictive values for 18- and 24-month 
CBE were compared using the R program SCPVTBT (www.ugr.es/~bioest/software.htm). Mixed-
effect analyses were conducted using PROC MIXED in SAS Version 9.4 (SAS Institute, Cary NC). 
All tests were two-sided, with α = 0.05. 
Results 
Table 2 provides stability and other classification indices at 18 and 24 months of age (using 
diagnosis at 36 months as the outcome standard) for this sample of 418 children at familial risk for 
ASD. More ASD diagnoses were made at 24 months (n = 79) than at 18 months (n = 44). This 
results in significant increases in sensitivity (p < 0.001) and decreases in the number of false 
negatives (p = 0.003) from 18 to 24 months of age. There is also a small but statistically significant 
decrease (p = 0.02) in positive predictive value from 18 months (93%) to 24 months (82%). This 
reflects the greater number of false positives at 24 months (n = 14) than at 18 months (n = 3). The 
18- and 24-month stability rates in this familial-risk sample fall within the range of, and are 
consistent with, the stability rates for children under age 3 in clinic- and community-ascertained 
samples reviewed in Table S1.  
-------------------------------------------------------- 
Insert Table 2 about here 
-------------------------------------------------------- 
As depicted in Figure 1, eight patterns of stability are generated when a dichotomous 
diagnostic decision (ASD or Not ASD) is made at three ages. Some children are consistently 
identified as ASD or Not ASD (i.e., AAA or NNN patterns in Table 4), others are classified in a way 
that evolves over time, in both directions (i.e., ANN, AAN, NAA, NNA), and still others move back 
and forth between ASD and Not ASD classifications at different ages (i.e., ANA, NAN). Due to the 
very small sample sizes in several of the subgroups and to allow for comparison with other studies 
that use the language of classification science (e.g., true and false positives and negatives), we 
consolidated the 8 patterns into four conservatively-defined stability groups. Diagnosis at 36 
months was used as the gold standard. A stable “positive” early assessment was defined as 
meeting criteria for ASD at 18 and 24 months (e.g., True Positives [TP] = AAA), while a stable 
“negative” early assessment was defined as not meeting criteria for ASD at both 18 and 24 months 
(e.g., True Negatives [TN] = NNN). The unstable groups were also defined conservatively, in that a 
classification at either 18 or 24 months that differed from the classification at 36 months led to 
inclusion in these groups. Thus, False Positives [FP] met ASD criteria at 18 and/or 24 months but 
not 36 months, while False Negatives [FN] failed to meet ASD criteria at 18 and/or 24 months but 
did at 36 months. The resulting classifications can be seen in Table 3.  
-------------------------------------------------------- 
Insert Figure 1 and Table 3 about here 
-------------------------------------------------------- 
Table 4 presents estimated means and 95% confidence intervals from the mixed-models for 
ADOS and Mullen scores for the four stability groups. Full details of these models are provided in 
Supplemental Table S2. Five sets of group differences were of interest (comparisons of the FP and 
FN groups to the TP and TN groups, as well as to each other) and are summarized in Table 4 and 
Figure 2.  
-------------------------------------------------------- 
Insert Table 4 and Figure 2 about here 
-------------------------------------------------------- 
At 18 and 24 months, the clinical features of the FN group were intermediate between the 
TP and TN groups. They had higher Mullen and lower ADOS scores than the TP group, but lower 
Mullen and higher ADOS scores than the TN group, suggesting that, although they were not yet 
diagnosed with ASD, they were atypical at 18 and 24 months. By 36 months, the FN and TP 
groups had similar ADOS scores, but the FN group’s Mullen remained higher than that of the TP 
group.  
The patterns of group differences were quite similar for the FP group, who, like the FN 
group, demonstrated Mullen and ADOS scores that were intermediate between and significantly 
different from both the TP and TN groups at 18 and 24 months. At 36 months, the Mullen scores of 
the FP group remained lower and their mean ADOS score was still higher than the TN group, so 
they demonstrated continued atypical development. However, their 36-month ADOS scores now 
differed from the TP group. 
We found no statistically significant differences between the FP and FN groups at either 18 
or 24 months; in addition, the confidence intervals were almost completely overlapping on every 
measure at both ages (see Table 4) and the effect sizes of the differences were in the small range 
(with the largest d across all scales = 0.3 at 18 months and 0.2 at 24 months). At 36 months, there 
continued to be no differences on the Mullen scales, but the FN group now had a significantly 
higher ADOS score than the FP group.  
Discussion 
This study had two aims: 1) to examine the stability at 36 months of a clinical diagnosis of 
ASD made at 18 and 24 months in young children at familial risk for ASD, and 2) to explore 
phenotypic differences among children who were correctly and incorrectly classified at 18 and 24 
months. The familial-risk design had a number of strengths. Improving upon previous studies, three 
longitudinal visits were conducted, the ages of which corresponded with screening ages 
recommended by the American Academy of Pediatrics (AAP; Johnson et al., 2007). In addition, the 
familial-risk cohort was not biased by clinical ascertainment or by the pre-screening selection 
methods often applied to community-based samples.  
Regarding Aim 1, the stability rates (i.e., positive predictive value estimates) of 93% at 18 
months and 82% at 24 months in this familial-risk sample were comparable to previous studies of 
both clinically and community ascertained samples younger than age three. The consistent positive 
predictive value across different types of samples provides some reassurance that previously 
published stability rates were not overly influenced by ascertainment methods. The high rates of 
diagnostic stability across studies and methodologies indicate that when ASD is identified at 18 or 
24 months, the diagnosis is very likely to be retained, so implementation of treatment should begin 
as soon as possible. 
The low sensitivity of an ASD diagnosis at 18 months and the decrease in stability from 18 
to 24 months suggest that there may have been age-dependent differences in clinical calibration 
operating in this familial-risk sample. It appears that at 18 months, clinicians monitored their 
decision-making such that if the clinical picture was not certain, they waited to make the diagnosis 
until later. Indeed, the ratio of false negatives to false positives approached 5:1, suggesting that 
clinicians’ ratings were conservative and biased towards committing as few positive identification 
errors as possible. But when clinicians were confident in identifying the phenotype, even at early 
ages (e.g., 18 months) and did make a diagnosis, they were generally correct and it was verified at 
subsequent visits. Another explanation for differences in clinical decision-making at the two ages 
may lie in the subclinical social and communication difficulties that have been documented in even 
very young siblings of children with ASD (Landa & Garrett-Mayer, 2006; Landa, Holman, & Garrett-
Mayer, 2007; Messinger et al., 2013; Ozonoff et al., 2014). Clinicians in this study needed to 
differentiate between emerging signs of ASD and subclinical features more consistent with the 
broader autism phenotype, a much more subtle distinction than ordinarily faced in a clinic setting. 
This may have encouraged clinicians in the current investigation to diagnose only the most 
affected children at 18 months of age.  
While negative predictive value at 18 months was respectable (81.6%), the number of false 
negatives was quite high. For many families who already have a child with ASD, hearing that their 
18-month-old does not meet criteria for a diagnosis will not be reassuring, given that the rate of 
missed diagnoses (18.4%) at this age is close to or higher than previously published recurrence 
rates for ASD (Ozonoff et al., 2011; Sandin et al., 2014).  One public health implication of this study 
is that screening may need to be repeated after 24 months, since many toddlers with ASD in this 
sample were not identified until three years of age. While the AAP’s screening guidelines (Johnson 
et al., 2007) were a step forward for clinical practice, our data suggest that they may need to go 
further still. For example, our results suggest that rescreening high-risk groups (e.g., siblings of 
children with ASD, children with developmental delays) at three years of age will identify some 
children whose ASD symptoms were not apparent at earlier ages.  
The second aim of this study was to examine what differentiates the diagnostically stable 
and unstable groups. The FP and FN groups demonstrated an intermediate phenotype, with higher 
developmental levels and fewer ASD features than the TP group, but lower developmental 
functioning and more ASD symptoms than the TN group. The FP and FN groups were very similar 
to each other in global scores on the developmental and diagnostic tests at 18 and 24 months, so it 
is intriguing to speculate on the factors involved in clinical decision-making that led a clinician to 
diagnose one child with ASD and to classify another child with similar scores as non-ASD.  There 
may have been particular symptom patterns that, when present, influenced clinicians to make (or 
not make) a clinical diagnosis. For example, a recent study identified several features at 18 months 
that were especially predictive of an ASD diagnosis, such as poor eye contact, lack of 
communicative gestures, and repetitive behaviors (Chawarska et al., 2014).  It is possible that, 
even with similar ADOS algorithm scores, the FP and FN groups differed in individual symptoms or 
constellations of symptoms. Factors not measured in the current study, such as medical and 
developmental history, level of parent or pediatrician concern, or delays in additional areas, such 
as motor or adaptive functioning, may also have influenced clinicians to make versus hold off on a 
diagnosis at 18 and 24 months.   
At each age, the FN group demonstrated significantly higher developmental functioning on 
the Mullen than the TP group. One interpretation of these data is that the FN group was composed 
of higher-functioning children with ASD who had a later onset of symptoms or whose symptoms 
were subtle at first and masked by age-appropriate language and cognitive abilities. These results 
are convergent with the results of a recent study that employed a data mining approach, rather 
than a CBE diagnostic process, to classify ASD at 18 months (Chawarska et al., 2014). In that 
study, a decision-tree learning algorithm identified correctly over half of the ASD cases at 18 
months, but missed those who had less pronounced developmental delays and fewer symptoms of 
ASD. This suggests that the high rate of false negatives in the current study might be linked with 
the developmental dynamics observed in young children developing ASD, rather than with 
particular classification methods.  
At 36 months, the FP group continued to demonstrate significantly lower Mullen and higher 
ADOS scores than the TN group. Thus, they continued to experience developmental difficulties, 
even though they no longer met criteria for an ASD diagnosis. More differentiated clinical outcomes 
were assigned at 36 months at each participating site. Of the 15 children in the False Positive 
group, only two were considered to be typically developing or have no diagnosis at 36 months. 
Over half (9 of the 15) children in the FP group demonstrated atypical social-communication 
features consistent with the broader autism phenotype, as has been found in other familial-risk 
samples (Georgiades et al., 2012; Messinger et al., 2013; Ozonoff et al., 2014). Two others in the 
FP group were classified at 36 months with speech-language delays, one with global 
developmental delays, and one with other developmental concerns that did not meet criteria for 
another clinical classification. This suggests that a history of atypical social-communication 
behavior at 18 or 24 months constitutes an important clinical indicator of later problems and 
suggests that these children should be monitored closely after age three, even though they may no 
longer meet ASD criteria. 
Some might wonder if the false positive cases in this study were actually children with 
“optimal outcomes” (Fein et al., 2013; Sutera et al., 2007), possibly secondary to early treatment. It 
is challenging, however, to compare the present investigation to previous studies of optimal 
outcome, which followed participants much longer, into later childhood. Intervention history data 
were available from only a few sites in the current study and the small sample size precluded 
formal analysis. Previous studies, however, have generally not found that number of intervention 
hours predicts outcome. In the meta-analysis of stability by Woolfenden et al. (2012), they note that 
in the subset of five studies that examined intervention hours as a predictor of outcome, none 
reported significant differences between the diagnostically stable and unstable groups. Anderson, 
Liang and Lord (2014) did not find that membership in their “very positive outcome group” was 
predicted by hours of treatment in early childhood. Orinstein et al. (2014) reported that children 
who lost their diagnosis were more likely to have received applied behavior analysis services than 
children who retained a diagnosis, but there were no differences between the outcome groups in 
number of hours of therapy. To better address the question, it is critical for future prospective 
studies to collect data in a systematic way on intervention history. 
In this familial-risk sample, false negatives were much more common than false positives, 
highlighting some of the consequences of using 24 months as a final outcome age in infant sibling 
study designs (e.g., Shen et al., 2013; Wolff et al., 2014). While the low rate of false positives and 
high stability may make this a tempting strategy in terms of funding and publication timelines, it 
does come at some cost. In this study, over 40% of the group diagnosed with ASD at outcome had 
not yet been identified at 24 months. While the high false negative rate in studies using 24 months 
as the age of final outcome may appear to present simply a conservative bias, the implications 
may be broader. Not only will the numbers of false negatives lead to misclassification at 24 
months, potentially affecting the statistical significance of group differences, but also they may 
result in a non-representative sample. In the present study, the group diagnosed with ASD at 24 
months had significantly more severe symptoms and lower developmental functioning than those 
who were not diagnosed until 36 months. As a result, it is possible that studies using a 24-month 
outcome may not be generalizable to the larger population of young children with ASD.  
What are the potential lessons learned from this study in terms of clinical decision-making 
and diagnosis of ASD at 18 and 24 months? Could we have identified the false negatives any 
earlier? Is there anything that distinguishes the false positives from the true positives that would 
have helped clinicians realize that they would not meet criteria later and their initial diagnosis was 
inaccurate? There are few answers to these questions in the current dataset. The FP and FN 
groups are both higher-functioning developmentally than the TP group, which may have clouded 
the clinical picture by interacting with the expression of autism symptoms. To improve early 
identification efforts in these clinically complex later-born siblings of children with ASD, future 
research could examine whether there are particular symptom patterns associated with accurate 
and inaccurate early classifications, as done recently by Chawarska and colleagues (2014) in a 
larger familial-risk sample. 
Although the labels of false positive and false negative were used in this study in 
accordance with conventions in classification science, they may be misleading or even 
inappropriate. The way these terms are usually employed in classification science is to indicate 
diagnostic errors or failures of the assessment protocol to identify true underlying patterns. In this 
study, however, inclusion in these groups may also be due to later emerging phenotypes or 
symptom patterns that change with age. The pattern of ADOS scores over time clearly falls in the 
FP group and rises in the FN group. Since all sites maintained high standards for initial training and 
ongoing reliability of ADOS administration, it is unlikely that clinician error resulted in these 
changing patterns over time. It is more likely that shifting phenotypes in the toddlers, transient 
autism signs in the former group and later emerging signs in the latter, are responsible for the 
changes in classification. Indeed, the pattern of rising ADOS scores in the FN group is consistent 
with multiple previous studies demonstrating a period in which symptoms are on the increase but 
have not yet reached levels at which a diagnosis can be confirmed (Landa & Garrett-Mayer, 2006; 
Ozonoff et al., 2010, 2014). The current data suggest that the unstable diagnostic classifications 
may not be diagnostic errors as much as they are reflections of an unfolding, emerging picture that 
goes in both directions (symptoms intensifying and lessening). Finally, it is worth reiterating that the 
“unstable” FP and FN groups were defined very conservatively in this study, with misclassifications 
at either 18 or 24 months leading to inclusion in these groups. While it may be alarming that such a 
large proportion of children with ASD went undiagnosed by expert clinicians in the second year of 
life, it is likely that many of these children were nonetheless eligible for early intervention services, 
given their lower developmental functioning and higher level of ASD symptoms than the TN group.  
Infancy is characterized by rapid changes in development as well as significant behavioral 
variability from moment to moment, features which themselves make early diagnosis challenging. 
Fisch (2012) cites low test-retest correlations across multiple developmental areas in infancy and 
points out the psychometric and norming limitations of many measures of infant development. Yet 
the stability of an ASD diagnosis, both in the present investigation and in numerous previous 
studies (Rondeau et al., 2011; Woolfenden et al., 2012), is impressive and is substantially higher 
than the stability rate reported for developmental delay classifications. Moura et al. (2010) studied 
a population-based cohort of 3,907 infants, tested at 12 months and again at 24 months with the 
Batelle Developmental Screening Inventory. Of the 390 suspected of developmental delay at 12 
months, only 58 continued to test positive at 24 months, yielding a stability estimate of 15% that is 
considerably lower than the 80% or better rates reported for ASD in the current and previous 
investigations. 
This study had several limitations. Infant sibling study designs have inherent biases that 
differ from clinic- and community-based investigations. Biased enrollment of infants with higher 
levels of parental concern cannot be ruled out. This, or other unknown biases of the infant sibling 
methodology, may have contributed to a slight (and not surprising, given the restrictive inclusion 
criteria) elevation in recurrence rate in this sample, relative to previously reported rates (Gronberg 
et al., 2013; Ozonoff et al., 2011; Sandin et al., 2014).  
Currently, there are no published studies comparing the clinical phenotypes of familial and 
non-familial cohorts and so the results of the present investigation may or may not generalize to 
the general population of young children with ASD. This caveat notwithstanding, it is critical that we 
understand the stability of early diagnoses in the familial-risk group.  Such children have the 
potential to be identified early, since the AAP recommends performing more intensive surveillance 
on infants with a positive family history of ASD (Johnson et al., 2007). The high stability and low 
rate of false positive diagnoses documented in the current study support the AAP guidelines for 
extra surveillance for this high-risk group and provide reassurance that early screening, 
assessment, and referral to intervention will not be wasted effort. However, the modest negative 
predictive value and high rate of false negatives found in the current study at 18 and 24 months 
also suggest that, even in the context of the intensified surveillance that occurs in infant sibling 
studies, not all children are demonstrating clear enough clinical phenotypes to be identified prior to 
36 months, particularly those with higher cognitive levels. More work is clearly needed to guide 
future surveillance efforts for this population.  
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Key Points 
  
Key	  Points	  
• Clinical	  diagnoses	  of	  ASD	  made	  before	  age	  3	  years	  have	  been	  shown	  in	  previous	  
research	  to	  be	  quite	  stable	  in	  samples	  of	  children	  ascertained	  from	  clinics	  or	  the	  
community.	  	  
• Stability	  was	  comparably	  high	  in	  a	  large	  sample	  of	  children	  under	  age	  3	  at	  
heightened	  familial	  risk	  for	  ASD.	  Few	  children	  were	  classified	  as	  having	  ASD	  at	  
18	  or	  24	  months	  who	  were	  not	  confirmed	  at	  36	  months.	  	  
• Sensitivity	  of	  the	  clinical	  diagnosis	  was	  relatively	  low	  at	  18	  and	  24	  months,	  with	  
close	  to	  half	  the	  sample	  not	  diagnosed	  until	  36	  months	  of	  age.	  
• These	  data	  suggest	  that	  screening	  for	  ASD	  should	  be	  repeated	  multiple	  times	  
during	  the	  first	  years	  of	  life.	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Table 1.  Characteristics of the sample (n = 418) 
Age at enrollment in months, mean 
(SD) 
7.0 (4.1) 
Gender, n (%) 
   Female 172 (41%) 
   Male 246 (59%) 
Outcome (36 months), n (%) 
   ASD 110 (26%) 
   Not ASD 308 (74%) 
Race1, n (%) 
   Caucasian 308 (83%) 
   Non-Caucasian 61 (17%) 
Hispanic2, n (%) 
   No 260 (95%) 
   Yes 14 (5%) 
Multiplex Status3, n (%) 
   No 343 (89%) 
   Yes 44 (11%) 
                         Note: ASD = autism spectrum disorder. 1Frequency Missing = 49; 2Frequency 
Missing =  144; 3Frequency Missing = 31
